Report : A-Z CDF items in Formulary 27/02/2021 10:20:29

[Back]

Section Status Homecare Name 13.05.03 Restricted Use Adalimumab Amgevita®,Humira®, Imraldi® 13.05.03 Restricted Use Apremilast Otezla® 03.04.02 Restricted Use Benralizumab Fasenra® 06.06.02 Non Formulary Burosumab Crysvita® 13.05.01 Restricted Use Dupilumab Dupixent® 02.11 Restricted Use Emicizumab Hemlibra® 13.05.03 Restricted Use Etanercept Enbrel®, Benepali® 03.07 Restricted Use Ivacaftor  03.04.03 Restricted Use Lanadelumab Takhzyro® 03.07 Restricted Use Lumacaftor/ivacaftor Orkambi® 10.02 Restricted Use Nusinersen Spinraza® 10.02 Restricted Use Risdiplam Evrysdi 13.05.03 Restricted Use Secukinumab Cosentyx® 03.07 Restricted Use Tezacaftor/Ivacaftor Symkevi® 13.05.03 Restricted Use Ustekinumab

Cambridgeshire and Peterborough